$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 15 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Option Exercise | A | 155.18 | 2,500 | 387,950 | 2,500 | |
May 15 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 152.98 | 200 | 30,596 | 22,423 | 22.6 K to 22.4 K (-0.88 %) |
May 15 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Grant | A | 0.00 | 1,000 | 0 | 22,623 | 21.6 K to 22.6 K (+4.62 %) |
May 12 2017 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Option Exercise | A | 155.18 | 2,500 | 387,950 | 2,500 | |
May 12 2017 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Grant | A | 0.00 | 1,000 | 0 | 21,527 | 20.5 K to 21.5 K (+4.87 %) |
May 12 2017 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Payment of Exercise | F | 155.18 | 641 | 99,470 | 20,527 | 21.2 K to 20.5 K (-3.03 %) |
May 12 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 153.68 | 17,927 | 2,754,932 | 278,491 | 296.4 K to 278.5 K (-6.05 %) |
May 12 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 153.17 | 12,073 | 1,849,214 | 296,418 | 308.5 K to 296.4 K (-3.91 %) |
May 10 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 160.00 | 2,500 | 400,000 | 37,149 | 39.6 K to 37.1 K (-6.31 %) |
May 08 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 159.06 | 939 | 149,357 | 21,623 | 22.6 K to 21.6 K (-4.16 %) |
May 05 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 158.38 | 1,565 | 247,865 | 40,348 | 41.9 K to 40.3 K (-3.73 %) |
Apr 28 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 160.00 | 2,500 | 400,000 | 39,649 | 42.1 K to 39.6 K (-5.93 %) |
Apr 27 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 160.00 | 1,275 | 204,000 | 21,133 | 22.4 K to 21.1 K (-5.69 %) |
Apr 19 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 152.56 | 200 | 30,512 | 22,562 | 22.8 K to 22.6 K (-0.88 %) |
Apr 13 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 152.12 | 1,000 | 152,120 | 308,491 | 309.5 K to 308.5 K (-0.32 %) |
Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 4,750 | 280,868 | 0 | |
Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 6,708 | 314,136 | 0 | |
Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 152.24 | 6,708 | 1,021,226 | 22,408 | 29.1 K to 22.4 K (-23.04 %) |
Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 6,708 | 314,136 | 29,116 | 22.4 K to 29.1 K (+29.94 %) |
Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 152.24 | 4,750 | 723,140 | 22,408 | 27.2 K to 22.4 K (-17.49 %) |
Apr 11 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 4,750 | 280,868 | 27,158 | 22.4 K to 27.2 K (+21.20 %) |
Mar 16 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 137.89 | 200 | 27,578 | 22,762 | 23 K to 22.8 K (-0.87 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 132.81 | 2,087 | 277,174 | 42,149 | 44.2 K to 42.1 K (-4.72 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 750 | 44,348 | 0 | |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 2,896 | 135,620 | 0 | |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 750 | 44,348 | 22,408 | 21.7 K to 22.4 K (+3.46 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 2,896 | 135,620 | 21,658 | 18.8 K to 21.7 K (+15.44 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 132.81 | 563 | 74,772 | 18,762 | 19.3 K to 18.8 K (-2.91 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 131.98 | 529 | 69,815 | 17,579 | 18.1 K to 17.6 K (-2.92 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 131.98 | 355 | 46,851 | 18,108 | 18.5 K to 18.1 K (-1.92 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 132.81 | 818 | 108,639 | 20,383 | 21.2 K to 20.4 K (-3.86 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 132.81 | 5,000 | 664,050 | 309,491 | 314.5 K to 309.5 K (-1.59 %) |
Mar 08 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 132.81 | 1,793 | 238,128 | 52,795 | 54.6 K to 52.8 K (-3.28 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 136.18 | 24,266 | 3,304,544 | 24,266 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 136.18 | 734 | 99,956 | 734 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Grant | A | 0.00 | 10,000 | 0 | 44,236 | 34.2 K to 44.2 K (+29.21 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 136.18 | 24,266 | 3,304,544 | 24,266 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 136.18 | 734 | 99,956 | 734 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 10,000 | 0 | 41,913 | 31.9 K to 41.9 K (+31.34 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 136.18 | 7,781 | 1,059,617 | 7,781 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 136.18 | 969 | 131,958 | 969 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,500 | 0 | 19,325 | 15.8 K to 19.3 K (+22.12 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 136.18 | 11,250 | 1,532,025 | 11,250 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 4,500 | 0 | 18,463 | 14 K to 18.5 K (+32.23 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 136.18 | 17,848 | 2,430,541 | 17,848 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 136.18 | 902 | 122,834 | 902 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Grant | A | 0.00 | 7,500 | 0 | 21,168 | 13.7 K to 21.2 K (+54.87 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Option Exercise | A | 136.18 | 17,848 | 2,430,541 | 17,848 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Option Exercise | A | 136.18 | 902 | 122,834 | 902 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Grant | A | 0.00 | 7,500 | 0 | 22,962 | 15.5 K to 23 K (+48.51 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Option Exercise | A | 136.18 | 11,250 | 1,532,025 | 11,250 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Grant | A | 0.00 | 4,500 | 0 | 21,201 | 16.7 K to 21.2 K (+26.94 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 136.18 | 85,766 | 11,679,614 | 85,766 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 136.18 | 734 | 99,956 | 734 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Grant | A | 0.00 | 34,600 | 0 | 314,491 | 279.9 K to 314.5 K (+12.36 %) |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 136.18 | 24,266 | 3,304,544 | 24,266 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | A | 136.18 | 734 | 99,956 | 734 | |
Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Grant | A | 0.00 | 10,000 | 0 | 54,588 | 44.6 K to 54.6 K (+22.43 %) |
Mar 01 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 136.97 | 1,994 | 273,118 | 31,913 | 33.9 K to 31.9 K (-5.88 %) |
Mar 01 2017 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 136.97 | 935 | 128,067 | 15,825 | 16.8 K to 15.8 K (-5.58 %) |
Mar 01 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 136.97 | 1,721 | 235,725 | 16,701 | 18.4 K to 16.7 K (-9.34 %) |
Mar 01 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 136.97 | 2,511 | 343,932 | 69,236 | 71.7 K to 69.2 K (-3.50 %) |
Feb 16 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 134.55 | 200 | 26,910 | 16,486 | 16.7 K to 16.5 K (-1.20 %) |
Jan 19 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 130.00 | 3,000 | 390,000 | 47,095 | 50.1 K to 47.1 K (-5.99 %) |
Jan 19 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 125.00 | 1,000 | 125,000 | 50,095 | 51.1 K to 50.1 K (-1.96 %) |
Jan 18 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 115.93 | 200 | 23,186 | 16,686 | 16.9 K to 16.7 K (-1.18 %) |
Dec 16 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 103.09 | 200 | 20,618 | 16,886 | 17.1 K to 16.9 K (-1.17 %) |
Dec 06 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 101.80 | 677 | 68,919 | 1,365 | 2 K to 1.4 K (-33.15 %) |
Nov 16 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 112.19 | 200 | 22,438 | 16,925 | 17.1 K to 16.9 K (-1.17 %) |
Nov 15 2016 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | P | 112.45 | 500 | 56,224 | 2,000 | 1.5 K to 2 K (+33.33 %) |
Nov 15 2016 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | P | 114.33 | 300 | 34,299 | 1,500 | 1.2 K to 1.5 K (+25.00 %) |
Nov 15 2016 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | P | 114.31 | 1,200 | 137,166 | 1,200 | 0 to 1.2 K |
Oct 18 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 118.16 | 200 | 23,632 | 17,125 | 17.3 K to 17.1 K (-1.15 %) |
Sep 20 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 126.17 | 200 | 25,234 | 17,325 | 17.5 K to 17.3 K (-1.14 %) |
Aug 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 129.42 | 4,620 | 597,908 | 1,048,008 | 1.1 M to 1 M (-0.44 %) |
Aug 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 128.97 | 10,283 | 1,326,191 | 1,052,628 | 1.1 M to 1.1 M (-0.97 %) |
Aug 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 127.70 | 9,500 | 1,213,177 | 1,062,911 | 1.1 M to 1.1 M (-0.89 %) |
Aug 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 126.65 | 3,565 | 451,511 | 1,072,411 | 1.1 M to 1.1 M (-0.33 %) |
Aug 18 2016 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 137.46 | 5 | 687 | 13,870 | 13.9 K to 13.9 K (-0.04 %) |
Aug 18 2016 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 137.47 | 1,287 | 176,921 | 13,875 | 15.2 K to 13.9 K (-8.49 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 136.45 | 633 | 86,373 | 15,391 | 16 K to 15.4 K (-3.95 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 136.45 | 633 | 86,373 | 6,116 | 6.7 K to 6.1 K (-9.38 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 136.45 | 633 | 86,373 | 4,953 | 5.6 K to 5 K (-11.33 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 136.45 | 685 | 93,468 | 6,076 | 6.8 K to 6.1 K (-10.13 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 136.45 | 633 | 86,373 | 2,042 | 2.7 K to 2 K (-23.66 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 136.45 | 633 | 86,373 | 5,234 | 5.9 K to 5.2 K (-10.79 %) |
Aug 16 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 136.45 | 100 | 13,645 | 17,525 | 17.6 K to 17.5 K (-0.57 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,365 | 0 | 16,024 | 14.7 K to 16 K (+9.31 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,365 | 0 | 6,749 | 5.4 K to 6.7 K (+25.35 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 1,365 | 0 | 5,175 | 3.8 K to 5.2 K (+35.83 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,365 | 0 | 5,586 | 4.2 K to 5.6 K (+32.34 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,365 | 0 | 12,107 | 10.7 K to 12.1 K (+12.71 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,365 | 0 | 1,075,976 | 1.1 M to 1.1 M (+0.13 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,365 | 0 | 6,761 | 5.4 K to 6.8 K (+25.30 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,365 | 0 | 6,754 | 5.4 K to 6.8 K (+25.33 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,365 | 0 | 2,675 | 1.3 K to 2.7 K (+104.20 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,365 | 0 | 5,867 | 4.5 K to 5.9 K (+30.32 %) |
Aug 12 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Buy | P | 137.26 | 1 | 137 | 14,182 | 14.2 K to 14.2 K (+0.01 %) |
Aug 12 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Buy | P | 137.10 | 607 | 83,218 | 14,181 | 13.6 K to 14.2 K (+4.47 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 150.01 | 9,071 | 1,360,741 | 290,113 | 299.2 K to 290.1 K (-3.03 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 150.01 | 9,071 | 1,360,741 | 290,113 | 299.2 K to 290.1 K (-3.03 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 1,000 | 150,000 | 299,184 | 300.2 K to 299.2 K (-0.33 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 1,000 | 150,000 | 299,184 | 300.2 K to 299.2 K (-0.33 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 150.01 | 1,467 | 220,065 | 16,710 | 18.2 K to 16.7 K (-8.07 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 150.01 | 1,467 | 220,065 | 16,710 | 18.2 K to 16.7 K (-8.07 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 150.01 | 4,565 | 684,796 | 36,699 | 41.3 K to 36.7 K (-11.06 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 150.01 | 2,729 | 409,377 | 18,422 | 21.2 K to 18.4 K (-12.90 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 150.01 | 4,565 | 684,796 | 36,699 | 41.3 K to 36.7 K (-11.06 %) |
Aug 11 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 150.01 | 2,729 | 409,377 | 18,422 | 21.2 K to 18.4 K (-12.90 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 148.66 | 4,000 | 594,640 | 51,038 | 55 K to 51 K (-7.27 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 150.01 | 4,565 | 684,796 | 55,038 | 59.6 K to 55 K (-7.66 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 148.66 | 4,000 | 594,640 | 51,038 | 55 K to 51 K (-7.27 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 149.02 | 978 | 145,742 | 59,603 | 60.6 K to 59.6 K (-1.61 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 150.01 | 4,565 | 684,796 | 55,038 | 59.6 K to 55 K (-7.66 %) |
Aug 10 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 149.02 | 978 | 145,742 | 59,603 | 60.6 K to 59.6 K (-1.61 %) |
Jul 18 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 142.43 | 100 | 14,243 | 17,625 | 17.7 K to 17.6 K (-0.56 %) |
Jul 13 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Buy | P | 143.63 | 580 | 83,305 | 13,574 | 13 K to 13.6 K (+4.46 %) |
Jun 16 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 149.64 | 100 | 14,964 | 17,725 | 17.8 K to 17.7 K (-0.56 %) |
Jun 15 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Buy | P | 149.61 | 557 | 83,335 | 12,994 | 12.4 K to 13 K (+4.48 %) |
May 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 151.51 | 4,726 | 716,036 | 1,074,611 | 1.1 M to 1.1 M (-0.44 %) |
May 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 150.72 | 9,954 | 1,500,305 | 1,079,337 | 1.1 M to 1.1 M (-0.91 %) |
May 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 149.64 | 11,888 | 1,778,893 | 1,089,291 | 1.1 M to 1.1 M (-1.08 %) |
May 26 2016 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 148.65 | 1,400 | 208,105 | 1,101,179 | 1.1 M to 1.1 M (-0.13 %) |
May 17 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 145.20 | 100 | 14,520 | 17,753 | 17.9 K to 17.8 K (-0.56 %) |
May 17 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 145.20 | 644 | 93,509 | 4,221 | 4.9 K to 4.2 K (-13.24 %) |
May 17 2016 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 145.20 | 697 | 101,204 | 5,396 | 6.1 K to 5.4 K (-11.44 %) |
May 13 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 145.23 | 815 | 118,362 | 33,809 | 34.6 K to 33.8 K (-2.35 %) |
May 12 2016 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Payment of Exercise | F | 148.76 | 641 | 95,355 | 12,399 | 13 K to 12.4 K (-4.92 %) |
May 06 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Payment of Exercise | F | 145.75 | 939 | 136,859 | 17,853 | 18.8 K to 17.9 K (-5.00 %) |
May 05 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 152.47 | 1,177 | 179,457 | 34,624 | 35.8 K to 34.6 K (-3.29 %) |
Apr 27 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 160.00 | 604 | 96,640 | 18,059 | 18.7 K to 18.1 K (-3.24 %) |
Mar 16 2016 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Sell | S | 129.17 | 100 | 12,917 | 18,892 | 19 K to 18.9 K (-0.53 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 127.84 | 1,550 | 198,152 | 64,470 | 66 K to 64.5 K (-2.35 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 127.84 | 563 | 71,974 | 25,831 | 26.4 K to 25.8 K (-2.13 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 127.84 | 818 | 104,573 | 21,151 | 22 K to 21.2 K (-3.72 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 127.84 | 1,832 | 234,203 | 41,141 | 43 K to 41.1 K (-4.26 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 126.04 | 2,500 | 315,100 | 300,066 | 302.6 K to 300.1 K (-0.83 %) |
Mar 09 2016 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 127.84 | 4,493 | 574,385 | 302,566 | 307.1 K to 302.6 K (-1.46 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 121.58 | 939 | 114,164 | 66,020 | 67 K to 66 K (-1.40 %) |
Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 121.58 | 422 | 51,307 | 35,801 | 36.2 K to 35.8 K (-1.17 %) |